Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002670327 | SCV003722409 | uncertain significance | Inborn genetic diseases | 2021-01-27 | criteria provided, single submitter | clinical testing | The c.2875C>T (p.R959C) alteration is located in exon 15 (coding exon 14) of the SPTBN4 gene. This alteration results from a C to T substitution at nucleotide position 2875, causing the arginine (R) at amino acid position 959 to be replaced by a cysteine (C). The p.R959C alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
3billion, |
RCV004725621 | SCV005328938 | likely benign | Neurodevelopmental disorder with hypotonia, neuropathy, and deafness | 2024-09-20 | criteria provided, single submitter | clinical testing | The homozygous variant was found in patients diagnosed with another variant in a different gene, with no symptoms related to the gene containing the homozygous variant. |